HROW · Harrow, Inc. · Webcasts, Transcripts & Audio
$30.43
-1.70 (-5.29%)
At close · Nov 20
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$1.14B
Shares
37.53M
Volume · Nov 20
910.57K
Avg daily vol (3M)
624.12K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Harrow, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Harrow, Inc. (HROW), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Pull transcripts and briefs through the earnings call transcript API or MCP →
Add these events to your calendar (.ics)
Conference
Investor event
2026-11-18
Harrow, Inc. (HROW) November 18, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-11-10
Harrow, Inc. (HROW) Q3 2026 Earnings Call Transcript
Positive tone
Vivi growth, coverage, and prescription economics
QUELL trial results and messaging potential
G-MELT regulatory filing
Revenue
$99.30M
▲ 38.6% YoY Diluted EPS
$0.25
▲ 733.3% YoY Gross margin
75.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-08-11
Harrow, Inc. (HROW) Q2 2026 Earnings Call Transcript
Confident tone
Second-half guidance and revenue acceleration
IHESO pricing and demand recovery
Viva franchise growth and economics
Revenue
$70.66M
▲ 10.9% YoY Diluted EPS
$-0.46
▼ 453.8% YoY Gross margin
71.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-03
Harrow, Inc. (HROW) June 3, 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-12
Harrow, Inc. (HROW) Q1 2026 Earnings Call Transcript
Confident tone
VEVYE demand and pricing dynamics
Commercial/sales force expansion
2026 full-year guidance
Revenue
$44.20M
▼ 7.6% YoY Diluted EPS
$-0.74
Gross margin
61.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-03-03
Harrow, Inc. (HROW) Q4 2025 Earnings Call Transcript
Confident tone
VEVYE growth and sales force expansion
TRIESENCE relaunch and sustainability
BYOOVIZ biosimilar launch and Samsung partnership
Revenue
$89.09M*
▲ 33.3% YoY Gross margin
79.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-11-11
Harrow, Inc. (HROW) Q3 2025 Earnings Call Transcript
Confident tone
VEVYE growth and market access
TRIESENCE and specialty portfolio
IHEEZO performance
Revenue
$71.64M
▲ 45.4% YoY Diluted EPS
$0.03
Gross margin
75.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-08-11
Harrow, Inc. (HROW) Q2 2025 Earnings Call
Confident tone
Revenue growth and guidance
VEVYE product momentum
IHEEZO retina growth
Revenue
$63.74M
▲ 30.2% YoY Diluted EPS
$0.13
Gross margin
74.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Harrow, Inc. (HROW) Q1 2025 Earnings Call Transcript
Confident tone
VEVYE commercial outlook
IHEEZO recovery and growth
Revenue guidance and seasonality
Revenue
$47.83M
▲ 38.3% YoY Diluted EPS
$-0.50
Gross margin
67.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-03-27
Harrow, Inc. (HROW) Q4 2024 Earnings Call
Revenue
$66.83M*
▲ 83.8% YoY Gross margin
78.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-14
Harrow, Inc. (HROW) Q3 2024 Earnings Call Transcript
Confident tone
VEVYE dry eye product
TRIESENCE relaunch
IHEEZO performance
Revenue
$49.26M
▲ 43.8% YoY Diluted EPS
$-0.12
Gross margin
75.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
Harrow, Inc. (HROW) Q2 2024 Earnings Call Transcript
Confident tone
VEVYE Dry Eye Franchise Success
IHEEZO Retina Product Launch
Market Access and Coverage Expansion
Revenue
$48.94M
▲ 46.2% YoY Diluted EPS
$-0.18
Gross margin
74.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-13
Harrow, Inc. (HROW) Q1 2024 Earnings Call Transcript
Confident tone
VEVYE launch and dry eye franchise
IHEEZO adoption and CMS reimbursement
Anterior Segment product portfolio
Revenue
$34.59M
▲ 32.5% YoY Diluted EPS
$-0.38
Gross margin
69.5%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-19
Harrow, Inc. (HROW) Q4 2023 Earnings Call Transcript
Confident tone
VEVYE launch and dry eye market
Triesence manufacturing and relaunch
Pricing philosophy and patient access
Revenue
$36.35M*
▲ 78.8% YoY Gross margin
68.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-13
Harrow, Inc. (HROW) Q3 2023 Earnings Call Transcript
Revenue
$34.27M
▲ 50.1% YoY Diluted EPS
$-0.13
Gross margin
70.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
Harrow, Inc. (HROW) Q2 2023 Earnings Call Transcript
Revenue
$33.47M
▲ 43.5% YoY Diluted EPS
$-0.14
Gross margin
70.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-11
Harrow, Inc. (HROW) Q1 2023 Earnings Call Transcript
Revenue
$26.10M
▲ 18% YoY Diluted EPS
$-0.22
Gross margin
68.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-23
Harrow, Inc. (HROW) Q4 2022 Earnings Call Transcript
Revenue
$20.33M*
▲ 0.7% YoY Gross margin
69.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-14
Harrow, Inc. (HROW) Q3 2022 Earnings Call Transcript
Revenue
$22.82M
▲ 22% YoY Diluted EPS
$-0.24
Gross margin
70.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-09
Harrow, Inc. (HROW) Q2 2022 Earnings Call Transcript
Revenue
$23.32M
▲ 28.6% YoY Diluted EPS
$-0.23
Gross margin
72.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Harrow, Inc. (HROW) Q1 2022 Earnings Call Transcript
Revenue
$22.12M
▲ 43.2% YoY Diluted EPS
$-0.09
▼ 1000% YoY Gross margin
73.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-10
Harrow, Inc. (HROW) Q4 2021 Earnings Call Transcript
Revenue
$20.19M*
▲ 38.3% YoY Gross margin
74.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-11-09
Harrow, Inc. (HROW) Q3 2021 Earnings Call Transcript
Revenue
$18.71M
▲ 29.9% YoY Diluted EPS
$-0.31
▼ 196.9% YoY Gross margin
73.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-10
Harrow, Inc. (HROW) Q2 2021 Earnings Call Transcript
Revenue
$18.13M
▲ 125% YoY Gross margin
75.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-04-14
Harrow, Inc. (HROW) Q1 2021 Earnings Call Transcript
Revenue
$15.44M
▲ 30.7% YoY Diluted EPS
$0.01
Gross margin
75.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-03-08
Harrow, Inc. (HROW) Q4 2020 Earnings Call Transcript
Revenue
$14.60M*
▲ 15.8% YoY Gross margin
73.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-09
Harrow, Inc. (HROW) Q3 2020 Earnings Call Transcript
Revenue
$14.40M
▲ 12.9% YoY Diluted EPS
$0.32
Gross margin
74.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-10
Harrow, Inc. (HROW) Q2 2020 Earnings Call Transcript
Revenue
$8.06M
▼ 40.4% YoY Diluted EPS
$-0.01
Gross margin
60.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-11
Harrow, Inc. (HROW) Q1 2020 Earnings Call Transcript
Revenue
$11.82M
▼ 3.8% YoY Diluted EPS
$-0.50
▼ 216.3% YoY Gross margin
69.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-03-13
Harrow, Inc. (HROW) Q4 2019 Earnings Call
Revenue
$12.60M*
▲ 10.7% YoY Gross margin
71.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–30 of 30 webcasts
Key facts
CIK
1360214
CUSIP
415858109
13F (30d)
212 filings
189 filers
Visit website
Investor relations